Investing in Liquid Biopsies

One of the more interesting companies in this space is Epic Sciences who recently announced the completion of a Series D funding round.  What is very interesting about Epic’s approach is their “no cell left behind” approach.  By maintaining all cells on a slide, there is an opportunity to better classify and categorize what is going on.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s